Immune cells not only remember viruses, but can also secrete tumor-fighting antibodies, say Weizmann Institute researchers; ...

The animals' B cells then underwent affinity maturation, producing potent human antibodies in a short amount of time. As a proof of concept, Farzan, Yin, and colleagues introduced the genomes for HIV ...

Scientists have discovered the key features of immune B cells that make them successful at targeting tumors—including when cancer has spread to a different part of the body. Scientists at the ...

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic ...

B cells can control responses of myeloid cells through the release of particular cytokines (small proteins that control the growth and activity of cells in the immune system), challenging the ...

Obinutuzumab tops immunosuppressant tacrolimus for membranous nephropathy remissions ...

The SunMo trial was evaluating the novel combination of mosunetuzumab and polatuzumab — not conventional chemotherapy, but a ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments in ...

B-cell chronic lymphocytic leukemia (CLL) occurs when abnormal B cells accumulate in the bone marrow and blood. This crowds out healthy blood cells and weakens the body’s ability to fight infections.

OLYMPIA-3 trial at ASCO 2026 shows odronextamab plus CHOP in higher-risk B-cell lymphoma delivers strong MRD-negative CRs ...